Subcutaneous formalin enhances outflow of met-enkephalin- and cholecystokinin-like materials in the rat nucleus accumbens

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 4, 2001, Pages 399-406

  Lapeyre, S ^a   Mauborgne, A ^a   Becker, C ^a   Benoliel, J J ^a   Cesselin, F ^a   Hamon, M ^a   Bourgoin, S ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cholecystokinin; Formalin; Freely moving rat; Met enkephalin; Microdialysis; Naloxone; Nucleus accumbens

Indexed keywords

CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; FORMALDEHYDE; METENKEPHALIN; NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FOREFOOT; MALE; MICRODIALYSIS; MOLECULAR INTERACTION; NEUROTRANSMISSION; NOCICEPTIVE STIMULATION; NONHUMAN; NUCLEUS ACCUMBENS; RAT;

ANIMALS; CHOLECYSTOKININ; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISINFECTANTS; ENKEPHALIN, METHIONINE; FORMALDEHYDE; MALE; MICRODIALYSIS; NALOXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035084647     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000377     Document Type: Article

References (51)

1. The formalin test: Scoring properties of the first and second phases of pain response in rats
2. The role of dopamine in the nucleus accumbens in analgesia
3. 2-Opioid receptor mediation of morphine-induced CCK release in the rat frontal cortex of the freely moving rat
4. Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra
5. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material
6. Social interaction increases the extracellular levels of [Met]enkephalin in the nucleus accumbens of control but not of chronic mild stressed rats
7. Subcutaneous formalin induces a segmental release of Met-enkephalin-like material from the rat spinal cord
8. Opioid and anti-opioid peptides
9. Increased levels of Met-enkephalin-like material in the CSF of anesthetized cats after tooth pulp stimulation
10. The dual inhibitor RB101 induces a long lasting increase in the extracellular level of met-enkephalin-like material in the nucleus accumbens of freely moving rats
11. Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the δ opioid system, in the nucleus ac-cumbens of rat
12. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brainstem stimulation in rats and cats
13. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia
14. Mixed-inhibitor-prodrug as a new approach towards systemically active inhibitors of enkephalin degrading enzymes
15. Antinociception produced by an ascending spino-supraspinal pathway
16. Pain-induced analgesia mediated by mesolimbic reward circuits
17. Immunohistochemical studies on cholecystokinin (CCK)-immunoreactive neurons in the rat using sequence specific antisera and with special reference to the caudate nucleus and primary sensory neurons
18. Nucleus accumbens: Transmitter histochemistry with reference to peptide-containing neurons
19. Noxious stimuli and Met-enkephalin release from nucleus reticularis gigantocellularis
20. Extracellular concentrations of met-enkephalin and cholecystokinin in the nucleus accumbens of freely moving rats following analgesic or algic treatments
21. Microdialysis of extracellular endogenous opioid peptides from rat brain in vivo
22. Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: Microdialysis combined with a sequential multiple antigen radioimmunoassay
23. Association of a peptidase inhibitor and a CCK-B antagonist strongly potentiates antinociception mediated by endogenous enkephalins
24. Morphine analgesia in the formalin test: Evidence for forebrain and midbrain sites of action
25. Endopeptidase 24-11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin (CCK-8)
26. Stress and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat: Prevention by diazepam but not ondansetron
27. A selective CCK-B receptor antagonist potentiates mu-, but not delta-opioid receptor-mediated antinociception in the formalin test
28. Pain-suppressive effects on various nociceptive stimuli (thermal, chemical, electrical and inflammatory) of the first orally active enkephalin-metabolizing enzyme inhibitor RB 120
29. Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey
30. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: Demonstration of an opioid kappa and delta inhibitory tone
31. Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model
32. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accum-bens of the rat via the CCK B receptor
33. Effects of CCK antagonists on GABA mechanism-induced antinociception in the formalin test
34. Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology
35. A serine peptidase responsible for the inactivation of endogenous cholecystokinin in the brain
36. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase
37. Opioidergic and adrenergic modulation of formalin-evoked spinal c-fos mRNA expression and nocifensive behavior in the rat
38. Involvement of medullary opioid-peptidergic and spinal noradrenergic systems in the regulation of formalin-induced persistent pain
39. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by β-endorphin and morphine administered intraventricularly in mice
40. Proglumide prevents and curtails acute tolerance to morphine in rats
41. Continuous intravenous infusion of naloxone does not change behavioral, cardiovascular, or inflammatory responses to subcutaneous formalin in the rat
42. Analgesia produced by normal doses of opioid antagonists alone and in combination with morphine
43. Cholecystokinin B antagonists strongly potentiate anti-nociception mediated by endogenous enkephalins
44. Naloxone causes apparent an-tinociception and pronociception simultaneously in the rat paw formalin test
45. Cholecystokinin antianalgesia: Safety cues abolish morphine analgesia
46. Chronic pain-related behaviors in spinally injured rats: Evidence for functional alterations of the endogenous cholecystokinin and opioid systems
47. CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level
48. The effect of intrathecally administered FK 480, a cholecystokinin-A receptor antagonist, and YM 022, a cholecystokinin-B receptor antagonist, on the formalin test in the rat
49. Nociceptive stimulus induces release of endogenous β-endorphin in the rat brain
50. Cholecystokinin-like immunoreactivity in the dorsal horn of the rat spinal cord: An attempt to analyse contradictory results between immunocytochemistry and radioimmunoassay